Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma
Abstract Due to immunosuppressive properties and confirmed tropism towards cancer cells mesenchymal stromal cells (MSC) have been used in many trials. In our study we used these cells as carriers of IL-12 in the treatment of mice with primary and metastatic B16-F10 melanomas. IL-12 has confirmed ant...
Guardado en:
Autores principales: | Natalia Kułach, Ewelina Pilny, Tomasz Cichoń, Justyna Czapla, Magdalena Jarosz-Biej, Marek Rusin, Alina Drzyzga, Sybilla Matuszczak, Stanisław Szala, Ryszard Smolarczyk |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/bcd4d466f3a84e96830b0f5ae3e9063f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
por: Ryszard Smolarczyk, et al.
Publicado: (2018) -
Outstanding Response to Sorafenib in a Patient with Metastatic Gastrointestinal Stromal Tumour
por: Charlotte Brinch, et al.
Publicado: (2021) -
Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer
por: Svitlana Tyekucheva, et al.
Publicado: (2017) -
Przydrożne sacrum w pamięci lokalnej
por: Stanisław Szczepan Cichoń
Publicado: (2020) -
Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer
por: Ciara H. O’Flanagan, et al.
Publicado: (2017)